Search PubMedSearch

PubMed · 8677404

Notes on conditional confidence limits under inverse sampling.

Abstract

When the number of subjects in a two-by-two table is small or moderate, we may commonly use the exact conditional distribution with all marginals fixed to derive the conditional confidence limits on the underlying parameter. Under inverse sampling, in which we continue to sample subjects until we obtain exactly a pre-determined number of subjects failing into a specific category, this paper notes that derivation of a confidence interval, which has the coverage probability equal to or larger than a nominal 1-alpha confidence level, for relative risk and relative difference in cohort studies is straightforward. This paper further finds that, when the underlying disease is rare, we can similarly apply an inverse sampling to produce an approximate 1-alpha conditional confidence limits on attributable risk in case-control studies as well. When the number of subjects is small and the test statistic derived on the basis of large sample theory is not strictly adequate for use, this paper also presents an exact hypothesis testing procedure for the above parameters in the corresponding study designs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K J Lui. 1995-09-30. Notes on conditional confidence limits under inverse sampling.. https://doi.org/10.1002/sim.4780141810

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Pulmonary hypertension after splenectomy?

BACKGROUND: A high prevalence of asplenia has been observed in patients with unexplained pulmonary hypertension. OBJECTIVE: To describe the clinical and histopathologic characteristics of patients with postsplenectomy pulmonary hypertension and to compare the prevalence of surgical asplenia in patients with idiopathic pulmonary hypertension and patients with other pulmonary diseases. DESIGN: Case series and case-control study. SETTING: University hospital in Hannover, Germany. PATIENTS: 61 patients with pulmonary hypertension and 151 lung transplant recipients. RESULTS: The prevalence of asplenia in patients with pulmonary hypertension was 11.5% (95% CI, 4.7% to 22.2%) compared with 0% (CI, 0% to 3.2%) in those without pulmonary hypertension (P < 0.001). Histopathologic examination of lung specimens from patients with postsplenectomy pulmonary hypertension showed intimal fibrosis, plexiform lesions, and abundant thrombotic lesions. CONCLUSION: Patients who have had splenectomy may be at increased risk for developing pulmonary hypertension.

Case-Control Studies

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.

BACKGROUND: Fatigue is a major disease and treatment burden for cancer patients. Several scales have been created to measure fatigue, but many are long and difficult for very ill patients to complete, or they are not easy to translate for non-English speaking patients. The Brief Fatigue Inventory was developed for the rapid assessment of fatigue severity for use in both clinical screening and clinical trials. METHODS: The study enrolled 305 consecutive, consenting adult inpatients and outpatients with cancer who could understand and complete the self-report measures used in the study. The same instruments also were administered to 290 community-dwelling adults to obtain a comparison sample. Research staff completed a form that indicated the primary site and stage of the cancer, rated the Eastern Cooperative Oncology Group performance status of the patient, described the characteristics of the pain, and described the current pain treatment being provided to the patients. RESULTS: The BFI was shown to be an internally stable (reliable) measure that tapped a single dimension, best interpreted as severity of fatigue. It correlated highly with similar fatigue measures. Greater than 98% of patients were able to complete it. A range of scores defining severe fatigue was identified. CONCLUSIONS: The BFI is a reliable instrument that allows for the rapid assessment of fatigue level in cancer patients and identifies those patients with severe fatigue.

Case-Control Studies